Recombinant HTLV-1 Protein (VAng-Lsx0308)
Datasheet
Specifications
Source
Human
Target
Human T-lymphotropic Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
Lyophilized from a solution containing 25mM Tris, 250mM Glycine and 0.1 % SDS.
Purity
> 95 % pure by 10 % SDS-PAGE and RP-HPLC.
Storage
Store at 2 °C to 8 °C short term, -20 °C long term.
Antigen Information
Introduction
The human T-lymphotropic virus (HTLV), is a group of human retroviruses that are known to cause a type of cancer called adult T-cell leukemia/lymphoma and a demyelinating disease called HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Studies show that HTLV belongs to a bigger family of primate T-lymphotropic viruses, also called as PTLVs. There are four members in this virus group have been found, including human T-lymphotropic virus type I (HTLV-1), human T-lymphotropic virus type II (HTLV-2), human T-lymphotropic virus type III (HTLV-3) and human T-lymphotropic virus type IV (HTLV-4).
Alternative Names
HTLV-1; Human T-lymphotropic virus; Simian T-lymphotropic virus; HTLV-1
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
